Search

Your search keyword '"Shi, Jian Hua"' showing total 106 results

Search Constraints

Start Over You searched for: Author "Shi, Jian Hua" Remove constraint Author: "Shi, Jian Hua"
106 results on '"Shi, Jian Hua"'

Search Results

2. Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study

5. The consistency of estimator under fixed design regression model with NQD errors

6. Strong asymptotic properties of kernel smoothing estimation for NA random variables with right censoring.

7. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

13. MCMC interweaving strategy for estimating stochastic volatility model and its application.

16. Internal profile reconstruction of microstructures based on near-infrared light transmission reflection interferometry with optical path compensation

17. Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

23. Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial

25. Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial

26. Explore the Effective Use of Multimedia Technology in College Physics Teaching

27. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

31. Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study

32. Research on Resolution of the Volume Holography Imaging Systems

35. Officiais Evaluation System Transformation, Pollution Discharge and Enterprise Production -- Based on Data of Industrial Enterprises of Jiangsu Province.

42. LUX-Lung 6: Patient-reported outcomes (PROs) from a randomized open-label, phase III study in first-line advanced NSCLC patients (pts) harboring epidermal growth factor receptor (EGFR) mutations.

43. LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) versus gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M+) advanced adenocarcinoma of the lung.

Catalog

Books, media, physical & digital resources